Mass High Tech

VIVOPATH

Is this your company?
Update it or Add a Logo
Logos place your company at the
top of the search results!

About:

VivoPath is a premier contract research organization working with Biotech and pharmaceutical companies to discover therapies for unmet medical needs. VivoPath provides rapid evaluation of compounds for in vivo proof of concept.

Headlines from Mass High Tech about VIVOPATH
Print this Listing

Product Information

Industry Classification Biopharma/Biotechnology
Primary Business Focus Biotechnology - Pharmaceutical
Other Business Offering Test/Research/Design Laboratories

Details

Year Established 2008
Ownership Type Private
Venture Funding Subscriber access only
No. of Employees at this location Subscriber access only
Total Number Employees Subscriber access only
Anticipated Workforce Changes Subscriber access only
Annual Sales Subscriber access only
% of Foreign Sales 3
Foreign Distribution Subscriber access only

Contacts

Philip Lambert Co-Founder/CSO email available to subscribers
Walter Lunsmann Co-Founder/COO email available to subscribers

* Downloads will not contain Personnel E-mail addresses

Search the Directory

(searches company name, description and industry categories)

Company Overview

Focus Biotechnology - Pharmaceutical
Location Worcester, MA
Size Subscriber access only
Website http://www.vivopath.com
Revenue Subscriber access only

Contact Information

Address 55 Union St
Redstone Center
Worcester, MA, 01608
Phone 508-751-5000
Fax 508-751-5001
Email Subscriber access only
Website www.vivopath.com

2012 New England Technology Directory Advertisers

New England Tech Directory | Browse | Subscribe | Advertise | Networking | About Us | Search | RSS Feeds | | Directory License | Update User Info | Directory Privacy Policy | Logout

© 2012 American City Business Journals, Inc. and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of bizjournals.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.